Hinge Health Q1 revenue $182M (+47% YoY), EPS $0.41; raises FY guidance to $801M

Hinge Health, Inc.

2026-Q1 EPS reported $0.41 revenue$182,307,000

Revenue of $182.3M, +47% YoY; GAAP diluted EPS $0.41, non-GAAP $0.45.
GAAP operating income $32.1M (+144% YoY); non-GAAP operating income $46.2M (+208% YoY).
Full year 2026 revenue guidance raised to $798M-$804M (midpoint $801M, +36% YoY).
Q2 2026 revenue guidance $194M-$196M, non-GAAP operating margin ~25%.
LTM calculated billings $769.9M (+52% YoY); clients up 23% to 2,849.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hinge Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $182.3 million, EPS $0.41. Guidance raised.

Period: the first quarter ended March 31, 2026
Revenue: $182.3 million
EPS: $0.41
Guidance: raised
Result: reported results

Exact text from the filing

results San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes

View on SEC.gov

Browse all earnings releases →

Hinge Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-030499

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.